Mersana Therapeutics Inc (MRSN) — Free Cash Flow Generation Index

Latest as of September 2022: 0.99x

Mersana Therapeutics Inc (MRSN) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $54.17 Million represents 1% of operating cash flow ($54.60 Million). Read MRSN total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$54.17 Million
USD

Operating Cash Flow

$54.60 Million
USD

Capital Expenditures

$426.00K
USD

Mersana Therapeutics Inc Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for Mersana Therapeutics Inc across 1 annual periods. Explore Mersana Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Mersana Therapeutics Inc (2016–2016)

Year-by-year Free Cash Flow Generation Index for Mersana Therapeutics Inc. For the full company profile including market capitalisation, see Mersana Therapeutics Inc market cap and net worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2016 0.97x $30.50 Million $31.59 Million $1.08 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).